AbbVie Income Statement (2012-2026) | ABBV

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	13.96B	14.34B	14.89B	13.54B	14.58B	14.81B	15.12B	12.22B	13.87B	13.93B	14.30B	12.31B	14.46B	14.46B	15.10B	13.34B	15.42B	15.78B	16.62B	15.00B
Cost of Revenue (Quarter)	4.52B	4.39B	4.32B	4.05B	4.17B	5.02B	4.17B	3.99B	4.24B	6.49B	5.70B	4.09B	4.20B	4.21B	4.40B	4.00B	4.35B	5.30B	4.55B	4.22B
Gross Profit (Quarter)	9.44B	9.95B	10.57B	9.49B	10.41B	9.79B	10.95B	8.24B	9.62B	7.44B	8.60B	8.22B	10.26B	10.25B	10.71B	9.34B	11.08B	10.47B	12.07B	10.78B
Operating items
Research & Development (Quarter)	1.77B	1.66B	1.83B	1.50B	1.61B	1.61B	1.79B	2.29B	1.73B	1.72B	1.93B	1.94B	1.95B	2.13B	6.77B	2.07B	2.13B	2.32B	2.58B	2.47B
Selling, General & Administrative (Quarter)	3.16B	3.08B	3.26B	3.13B	5.41B	3.30B	3.42B	3.04B	3.27B	3.37B	3.19B	3.31B	3.38B	4.21B	3.85B	3.29B	3.25B	3.57B	3.90B	3.58B
Other Operating Expenses (Quarter)	0.07B	0.50B			0.17B	-0.23B	0.00B	0.01B	0.17B						0.01B	4.25B	0.02B		0.22B	4.96B
Operating Expenses (Quarter)	9.52B	10.04B	9.81B	8.82B	11.29B	10.21B	9.62B	9.46B	9.35B	11.65B	11.11B	9.51B	10.46B	10.63B	16.59B	9.61B	10.53B	13.87B	12.07B	11.01B
Operating Income (Quarter)	4.44B	4.31B	5.07B	4.72B	3.29B	4.60B	5.50B	2.77B	4.51B	2.28B	3.19B	2.80B	4.00B	3.83B	-1.49B	3.73B	4.89B	1.90B	4.54B	3.99B
EBIT (Quarter)	4.44B	4.31B	5.07B	4.72B	3.29B	4.60B	5.50B	2.77B	4.51B	2.28B	3.19B	2.80B	4.00B	3.83B	-1.49B	3.73B	4.89B	1.90B	4.54B	3.99B
Non-operating items
Interest & Investment Income (Quarter)	-0.61B	-0.58B	-0.57B	-0.54B	-0.53B	-0.50B	-0.48B	-0.45B	-0.45B	-0.40B	-0.38B	-0.45B	-0.51B	-0.59B	-0.61B	-0.63B	-0.68B	-0.67B	-0.66B	-0.65B
Other Non Operating Income (Quarter)	-0.01B	-0.01B	-0.22B	0.78B	-0.05B	0.33B	0.28B	-0.04B	-1.41B	0.10B	-4.58B	-0.59B	-1.34B	-1.16B	3.07B	-1.45B	-2.64B	-0.50B	-5.75B	-2.31B
Non Operating Income (Quarter)	-2.66B	-0.02B	-0.22B	0.78B	-1.53B	0.33B	-2.02B	-1.80B	-1.41B	0.10B	-1.56B	-0.59B	-1.34B	-1.16B	-0.15B	-1.45B	-2.64B	-0.50B	-1.21B	-2.31B
Net income details
EBT (Quarter)	1.16B	3.69B	4.27B	4.93B	1.18B	4.40B	2.96B	0.47B	2.61B	1.95B	1.21B	1.75B	2.15B	2.08B	-2.27B	1.66B	1.55B	0.71B	2.67B	1.04B
Tax Provisions (Quarter)	0.39B	0.51B	0.23B	0.44B	0.26B	0.45B	0.49B	0.57B	0.58B	0.17B	0.39B	0.38B	0.77B	0.52B	-2.25B	0.37B	0.61B	0.53B	0.85B	0.34B
Profit After Tax (Quarter)	0.77B	3.18B	4.04B	4.49B	0.92B	3.95B	2.47B	0.24B	2.02B	1.78B	0.82B	1.37B	1.37B	1.56B	-0.02B	1.29B	0.94B	0.19B	1.82B	0.70B
Net Income - Minority (Quarter)	-0.03B
Income from Non-Controlling Interests (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B
Income from Continuing Operations (Quarter)	0.77B	3.18B	4.04B	4.49B	0.93B	3.95B	2.47B	-0.10B	2.03B	1.78B	0.82B	1.37B	1.37B	1.56B	-0.02B	1.29B	0.94B	0.19B	1.81B	0.70B
Consolidated Net Income (Quarter)	0.77B	3.18B	4.04B	4.49B	0.93B	3.95B	2.47B	-0.10B	2.03B	1.78B	0.82B	1.37B	1.37B	1.56B	-0.02B	1.29B	0.94B	0.19B	1.81B	0.70B
Income towards Parent Company (Quarter)	0.74B	3.18B	4.04B	4.49B	0.93B	3.95B	2.47B	-0.10B	2.03B	1.78B	0.82B	1.37B	1.37B	1.56B	-0.02B	1.29B	0.94B	0.19B	1.81B	0.70B
Net Income towards Common Stockholders (Quarter)	0.74B	3.18B	4.04B	4.49B	0.93B	3.95B	2.47B	-0.10B	2.03B	1.78B	0.82B	1.37B	1.37B	1.56B	-0.02B	1.29B	0.94B	0.19B	1.81B	0.70B
Additional items
EPS (Basic) (Quarter)	0.42	1.78	2.27	2.52	0.52	2.22	1.39	0.13	1.14	1.00	0.46	0.77	0.77	0.88	-0.02	0.72	0.52	0.10	1.02	0.39
EPS (Weighted Average and Diluted) (Quarter)	0.42	1.78	2.26	2.51	0.51	2.21	1.38	0.13	1.14	1.00	0.46	0.77	0.77	0.88	-0.02	0.72	0.52	0.10	1.02	0.39
Shares Outstanding (Weighted Average) (Quarter)	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B
Shares Outstanding (Diluted Average) (Quarter)	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B
EBITDA (Quarter)	4.44B	4.31B	5.07B	4.72B	3.29B	4.60B	5.50B	2.77B	4.51B	2.28B	3.19B	2.80B	4.00B	3.83B	-1.49B	3.73B	4.89B	1.90B	4.54B	3.99B
Interest Expenses (Quarter)
Tax Rate (Quarter)	33.88%	13.77%	5.29%	8.85%	21.56%	10.18%	16.63%	120.42%	22.34%	8.81%	32.01%	21.82%	36.02%	24.95%	98.99%	22.40%	39.45%	73.67%	31.97%	32.92%

Research Tools

AbbVie Income Statement (2012-2026) | ABBV

Create an account

Sign In

Reset Password